Zimbabwe: New treatment guidelines rolled out – a year later

Zimbabwe's government adopted new guidelines set by the World Health Organisation (WHO) for treating people living with HIV almost a year ago, but funding constraints have made it difficult to implement them - until now. On 1 April 2011, Zimbabwe started phasing out the combination antiretroviral treatment (ARV) Stavudine, Lamivudine and Nevirapine as its first-line option for the national programme, replacing it with the less toxic Tenofovir-based regimens for adults and Zidovudine-based regimens for children, as recommended by the 2010 WHO guidelines.